Cargando…
Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up
Adrenomedullin (ADM) is a peptide with pleiotropic effects in systemic inflammation. Its more stable precursor protein midregional proadrenomedullin (MRproADM) can be measured more reliably compared to ADM. Our objective was to investigate the potential role of MRproADM as a diagnostic and prognosti...
Autores principales: | Buendgens, Lukas, Yagmur, Eray, Ginsberg, Axel, Weiskirchen, Ralf, Wirtz, Theresa, Jhaisha, Samira Abu, Eisert, Albrecht, Luedde, Tom, Trautwein, Christian, Tacke, Frank, Koch, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428945/ https://www.ncbi.nlm.nih.gov/pubmed/32831638 http://dx.doi.org/10.1155/2020/7184803 |
Ejemplares similares
-
Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia
por: Gordo-Remartínez, Susana, et al.
Publicado: (2015) -
Clusterin Plasma Concentrations Are Decreased in Sepsis and Inversely Correlated with Established Markers of Inflammation
por: Yagmur, Eray, et al.
Publicado: (2022) -
Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients
por: Puengel, Tobias, et al.
Publicado: (2021) -
Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients
por: Wirtz, Theresa H., et al.
Publicado: (2020) -
Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients
por: Wirtz, Theresa H., et al.
Publicado: (2020)